AKR1C1 and breast carcinoma: Our studies indicated that DIF-1 (a.k.a IRF-2BP2) acts to selectively repress one or more pro-apoptotic genes in breast cancer cells (but not in the other cell types examined) and this repression is reversed by the binding of NRIF3/DD1 [4].